ICAM1 and head and neck squamous cell carcinoma: PIO-mediated inhibition of ICAM1 potentially contributed to reduced spheroid formation (Figure 4G) and cell invasion (Figure 4H) as well as sensitization to DTX in CM-treated HNSCC cells (Figure 4I).